"A Two Year Open Label, Randomized, Parallel Group, Blinded Assessment Ophthalmologic Safety Study of Pramipexole IR versus Ropinirole in Early Parkinson's Disease Patients" by Kelly L. Sullivan

Other

A Two Year Open Label, Randomized, Parallel Group, Blinded Assessment Ophthalmologic Safety Study of Pramipexole IR versus Ropinirole in Early Parkinson's Disease Patients

(2007)

Kelly L. Sullivan, Georgia Southern University

Disciplines

Epidemiology and
Public Health

Publication Date

2007

Citation Information

Kelly L. Sullivan (Coordinator), "A Two Year Open Label, Randomized, Parallel Group, Blinded Assessment Ophthalmologic Safety Study of Pramipexole IR versus Ropinirole in Early Parkinson's Disease Patients," Boehringer Ingelheim, Protocol # 248.538. (2007-2011).